Literature DB >> 28203832

Metabolic cardiomyopathies - fighting the next epidemic.

Christoph Maack1, Elizabeth Murphy2.   

Abstract

Entities:  

Year:  2017        PMID： 28203832      PMCID： PMC5852643          DOI： 10.1093/cvr/cvx022

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  22 in total

1.  ATF3 expression in cardiomyocytes preserves homeostasis in the heart and controls peripheral glucose tolerance.

Authors:  Roy Kalfon; Lilach Koren; Sharon Aviram; Ortal Schwartz; Tsonwin Hai; Ami Aronheim
Journal:  Cardiovasc Res       Date:  2016-11-07       Impact factor: 10.787

Review 2.  First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics.

Authors:  Hazel H Szeto
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

3.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur J Heart Fail       Date:  2016-05-20       Impact factor: 15.534

4.  Nutritional Ketosis Alters Fuel Preference and Thereby Endurance Performance in Athletes.

Authors:  Pete J Cox; Tom Kirk; Tom Ashmore; Kristof Willerton; Rhys Evans; Alan Smith; Andrew J Murray; Brianna Stubbs; James West; Stewart W McLure; M Todd King; Michael S Dodd; Cameron Holloway; Stefan Neubauer; Scott Drawer; Richard L Veech; Julian L Griffin; Kieran Clarke
Journal:  Cell Metab       Date:  2016-07-27       Impact factor: 27.287

5.  Mitochondrial complex I defect and increased fatty acid oxidation enhance protein lysine acetylation in the diabetic heart.

Authors:  Edwin J Vazquez; Jessica M Berthiaume; Vasudeva Kamath; Olisaemeka Achike; Elizabeth Buchanan; Monica M Montano; Margaret P Chandler; Masaru Miyagi; Mariana G Rosca
Journal:  Cardiovasc Res       Date:  2015-06-22       Impact factor: 10.787

Review 6.  Sodium-glucose cotransporter-2 inhibition for the reduction of cardiovascular events in high-risk patients with diabetes mellitus.

Authors:  Nikolaus Marx; Darren K McGuire
Journal:  Eur Heart J       Date:  2016-05-05       Impact factor: 29.983

Review 7.  Inflammation and metabolic cardiomyopathy.

Authors:  Kazuhiko Nishida; Kinya Otsu
Journal:  Cardiovasc Res       Date:  2017-03-15       Impact factor: 10.787

Review 8.  An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy.

Authors:  Giacomo Frati; Leonardo Schirone; Isotta Chimenti; Derek Yee; Giuseppe Biondi-Zoccai; Massimo Volpe; Sebastiano Sciarretta
Journal:  Cardiovasc Res       Date:  2017-03-15       Impact factor: 10.787

9.  Global trends and projections for tobacco use, 1990-2025: an analysis of smoking indicators from the WHO Comprehensive Information Systems for Tobacco Control.

Authors:  Ver Bilano; Stuart Gilmour; Trevor Moffiet; Edouard Tursan d'Espaignet; Gretchen A Stevens; Alison Commar; Frank Tuyl; Irene Hudson; Kenji Shibuya
Journal:  Lancet       Date:  2015-03-14       Impact factor: 79.321

10.  Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants.

Authors: 
Journal:  Lancet       Date:  2016-04-06       Impact factor: 79.321
View more
  3 in total

1.  Quantitative proteomics analysis based on tandem mass tag labeling coupled with labeling coupled with liquid chromatography-tandem mass spectrometry discovers the effect of silibinin on non-alcoholic fatty liver disease in mice.

Authors:  Yichao Wang; Hang Zhao; Liying Yang; He Zhang; Xian Yu; Wenjie Fei; Yunfeng Zhen; Zhe Gao; Shuchun Chen; Luping Ren
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

Review 2.  Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology.

Authors:  Jolanda van der Velden; Carlo G Tocchetti; Gilda Varricchi; Anna Bianco; Vasco Sequeira; Denise Hilfiker-Kleiner; Nazha Hamdani; Adelino F Leite-Moreira; Manuel Mayr; Ines Falcão-Pires; Thomas Thum; Dana K Dawson; Jean-Luc Balligand; Stephane Heymans
Journal:  Cardiovasc Res       Date:  2018-08-01       Impact factor: 10.787

3.  Acetyl-CoA production by specific metabolites promotes cardiac repair after myocardial infarction via histone acetylation.

Authors:  Ienglam Lei; Shuo Tian; Wenbin Gao; Liu Liu; Yijing Guo; Paul Tang; Eugene Chen; Zhong Wang
Journal:  Elife       Date:  2021-12-23       Impact factor: 8.140
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.